Pacemaker Market Research Report - Global Forecast till 2027

Global Pacemaker Market Research Report: Information by Implantability (Implantable Pacemakers and External Pacemaker), Technology (Dual-Chamber Pacemakers, Single-Chamber Pacemakers and Biventricular/CRT Pacemakers), Type (MRI Compatible Pacemakers and Conventional Pacemakers), End User (Hospitals & Cardiac Centers and Ambulatory Surgical Centers) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/1058-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2020-2025 to 2020-2027. Cordially fill Sample form for the updated data.

Market Scenario


Pacemaker Market is projected to reach USD 4.2 Billion in 2018 and expected to register a 2.5% CAGR during the forecast period. The pacemaker is a small device implanted in the chest to regulate abnormal heart rhythm. Pacemakers are used in medical conditions such as arrhythmia, atrial fibrillation, heart block, and long QT syndrome. The primary factors driving the growth of global pacemaker market are rising incidences of cardiovascular disorders, technological advancements in pacemakers, and increasing research and development for pacemakers.


According to the American Heart Association, cardiovascular disorders (CVD) is the leading cause of death globally, accounting for more than 17.6 million deaths per year in 2016. Additionally, the rising healthcare expenditure for cardiovascular disorders is driving market growth. For instance, according to the American Heart Association, CVD and stroke accounted for 14% of total health expenditures in 2016. This rise in cardiovascular cases and rising healthcare expenditure is expected to drive the market growth.


However, the high cost of pacemakers and unfavorable reimbursement scenarios may hinder the market growth during the forecasted period.


Segmentation


Global Pacemaker Market has been segmented into implantability, technology, type, and end users.


By implantability, the global market has been divided into implantable pacemakers and external pacemakers.


 On the basis of technology, the global market has been segmented into dual-chamber pacemakers, single-chamber pacemakers, and biventricular/CRT pacemakers.


Based on type, the global market has been bifurcated into MRI compatible pacemakers and conventional pacemakers.


On the basis of end user, the global market has been divided into hospitals & cardiac centers and ambulatory surgical centers.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The pacemaker market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European pacemaker market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The pacemaker market in Asia-Pacific has been segmented into Japan, China, India, Latin Korea, Australia, and the rest of Asia-Pacific. The pacemaker market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key Players


Medtronic (Dublin, Ireland), Abbott Laboratories (US), Boston Scientific (US), Biotronik (Germany), Livanova (UK), Lepu Medical (China), Shree Pacetronix (India), Osypka Medical (Germany), Medico Spa (Italy), and Oscor (US) are some of the key players operating in the global pacemaker market.


Regional Market Summary


Global Pacemaker Market Share (%), by Region, 2018  Pacemaker Market


Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, Annual Reports


Geographically, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas dominated the pacemaker market owing to the increasing prevalence of cardiovascular disorders, growing geriatric population, and rapid technological advancements. According to the Centers for Disease Control and Prevention, every year about 735,000 Americans have a heart attack. Additionally, the American Heart Association stated that by 2035 more than 130 million adults or 45.1% of the US population are expected to have some form of CVD in their lifetime.  


Europe is expected to be the second-largest region in the pacemaker market owing to the increasing health problems such as hypertension, stress, obesity, and changing lifestyles. Additionally, the increasing cases of CVD and rising initiatives to create awareness is driving the growth of the pacemaker market in the region. For instance, the European Commission and the European Heart Network (EHN) established the European Heart Health Initiative (EHHI) to prevent cardiovascular diseases (CVDs). Such initiatives promote to drive the growth of the pacemaker market in Europe.


Asia-Pacific was anticipated to be the fastest-growing region in the pacemaker market. The market in the region is expected to witness growth owing to the increasing population and rising demand for technologically advanced products. The prevalence of CVD is high in developing countries and cities, such as Japan, Hong Kong, and Singapore, which support market growth.


The market in the Middle East & Africa holds a low share in the pacemaker market due to the presence of a low number of healthcare facilities, low per capita income, and limited awareness of upcoming treatment methods in underdeveloped countries. However, the market is expected to witness growth due to increasing hospitals and rising demand for pacemakers in the Middle East.


Global Pacemaker Market, by Implantability



  • Implantable Pacemakers

  • External Pacemaker


Global Pacemaker Market, by Technology   



  • Dual-Chamber Pacemakers

  • Single-Chamber Pacemakers

  • Biventricular/CRT Pacemakers


Global Pacemaker Market, by Type



  • MRI Compatible Pacemakers

  • Conventional Pacemakers


Global Pacemaker Market, by End User



  • Hospitals & Cardiac Centers

  • Ambulatory Surgical Centers


Global Pacemaker Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • Latin Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Cardiovascular disorders treatment centers

  • Contract research organizations (CROs)

  • Research and development (R&D) companies

  • Government research laboratories

  • Independent research laboratories

  • Government and independent regulatory authorities

  • Market research and consulting service providers

  • Medical research laboratories

  • Academic medical institutes and universities



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 4.2 Billion (2018)
  CAGR   2.5% (2020 - 2025)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   by Implantability, Technology, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Medtronic (Dublin, Ireland), Abbott Laboratories (US), Boston Scientific (US), Biotronik (Germany), Livanova (UK), Lepu Medical (China), Shree Pacetronix (India), Osypka Medical (Germany), Medico Spa (Italy), and Oscor (US)
  Key Market Opportunities

  • The primary factors driving the growth of global pacemaker market are rising incidences of cardiovascular disorders.\r\n
  • Technological advancements in pacemakers, and increasing research and development for pacemakers.
  •   Key Market Drivers   The high cost of pacemakers and unfavorable reimbursement scenarios may hinder the market growth during the forecasted period.


    Frequently Asked Questions (FAQ) :


    The valuation of the global pacemaker market had reached USD 4.2 BN in 2018.

    pacemaker market is projected to grow at approximately 2.5% CAGR during the assessment period (2019-2025).

    Rising incidences of cardiovascular disorders, technological advances in pacemakers, and increasing R&D expenses for pacemakers are the major tailwinds pushing the growth of the global pacemaker market.

    North America holds the largest share in the global pacemaker market, followed by Europe and the Asia Pacific, respectively.

    Biotronik GmbH & Co. KG (Germany), ATS Medical (US), Boston Scientific Corporation (US), Medtronic Plc (US), Edwards Lifesciences (US), Sorin Group, St. Jude Medical Inc. (US), Zoll Medical Corporation (US), and Vitatron Holding B.V. (the Netherlands), are some of the major players operating in the pacemaker market.

    Table of Content

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    Chapter 5. Market Factor Analysis

    5.1 Porters Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    Chapter 6. Global Pacemaker Market, by Implantability

    6.1 Introduction

    6.2 Implantable Pacemakers

    6.3 External Pacemaker

    Chapter 7. Global Pacemaker Market, by Technology

    7.1 Introduction

    7.2 Dual-Chamber Pacemakers

    7.3 Single-Chamber Pacemakers

    7.4 Biventricular/CRT Pacemakers

    Chapter 8. Global Bipolar Disorders and Treatment Market, by Type

    8.1 Introduction

    8.2 MRI Compatible Pacemakers

    9.3 Conventional Pacemakers

    Chapter 8. Global Bipolar Disorders and Treatment Market, by End User

    8.1 Introduction

    8.2 Hospitals & Cardiac Centers

    9.3 Ambulatory Surgical Centers

    Chapter 9. Global Pacemaker Market, by Region

    9.1 Introduction

    9.2 America

    9.2.1 North America

    9.2.1.1 US

    9.2.1.2 Canada

    9.2.2 Latin America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 UK

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia-Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 Republic of Korea

    9.4.6 Rest of Asia-Pacific

    9.5 Middle East & Africa

    9.5.1 Middle East

    9.5.2 Africa

    Chapter 10. Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    Chapter 11 Company Profiles

    11.1 Medtronic

    11.1.1 Company Overview

    11.1.2 Type Overview

    11.1.3 Financial Overview

    11.1.4 Key Developments

    11.1.5 SWOT Analysis

    11.2 Abbott Laboratories

    11.2.1 Company Overview

    11.2.2 Type Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 Boston Scientific

    11.3.1 Company Overview

    11.3.2 Type Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Biotronik

    11.4.1 Company Overview

    11.4.2 Segment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 Livanova

    11.5.1 Company Overview

    11.5.2 Type Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.5.5 SWOT Analysis

    11.6 Lepu Medical

    11.6.1 Company Overview

    11.6.2 Type Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.6.5 SWOT Analysis

    11.7 Shree Pacetronix

    11.7.1 Overview

    11.7.2 Type Overview

    11.7.3 Financial Overview

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 Osypka Medical

    11.8.1 Overview

    11.8.2 Type Overview

    11.8.3 Financial Overview

    11.8.4 Key Developments

    11.8.5 SWOT Analysis

    11.9 Medico Spa

    11.9.1 Overview

    11.9.2 Type Overview

    11.9.3 Financial Overview

    11.9.4 Key Developments

    11.9.5 SWOT Analysis

    11.10 Oscor

    11.10.1 Overview

    11.10.2 Type Overview

    11.10.3 Financial Overview

    11.10.4 Key Developments

    11.10.5 SWOT Analysis

    11.11 Others

    Chapter 12. Appendix

    LIST OF TABLES

    Table 1 Global Pacemaker Synopsis, 2020-2027

    Table 2 Global Pacemaker Market Estimates and Forecast, 2020-2027, (USD Million)

    Table 3 Global Pacemaker Market, by Region 2020-2027, (USD Million)

    Table 4 Global Pacemaker Market, by Implantability 2020-2027, (USD Million)

    Table 5 Global Pacemaker Market, by Technology 2020-2027, (USD Million)

    Table 5 Global Pacemaker Market, by Type 2020-2027, (USD Million)

    Table 6 Global Pacemaker Market, by End User 2020-2027, (USD Million)

    Table 7 North America: Pacemaker Market, by Implantability 2020-2027, (USD Million)

    Table 8 North America: Pacemaker Market, by Technology 2020-2027, (USD Million)

    Table 8 North America: Pacemaker Market, by Type 2020-2027, (USD Million)

    Table 9 North America: Pacemaker Market, by End User 2020-2027, (USD Million)

    Table 10 US: Pacemaker Market, by Implantability 2020-2027, (USD Million)

    Table 11 US: Pacemaker Market, by Technology 2020-2027, (USD Million)

    Table 8 US: Pacemaker Market, by Type 2020-2027, (USD Million)

    Table 12 US: Pacemaker Market, by End User 2020-2027, (USD Million)

    Table 13 Canada: Pacemaker Market, by Implantability 2020-2027, (USD Million)

    Table 14 Canada: Pacemaker Market, by Technology 2020-2027, (USD Million)

    Table 8 Canada: Pacemaker Market, by Type 2020-2027, (USD Million)

    Table 15 Canada: Pacemaker Market, by End User 2020-2027, (USD Million)

    Table 16 Latin America: Pacemaker Market, by Implantability 2020-2027, (USD Million)

    Table 17 Latin America: Pacemaker Market, by Technology 2020-2027, (USD Million)

    Table 8 Latin America: Pacemaker Market, by Type 2020-2027, (USD Million)

    Table 18 Latin America: Pacemaker Market, by End User 2020-2027, (USD Million)

    Table 19 Europe: Pacemaker Market, by Implantability 2020-2027, (USD Million)

    Table 20 Europe: Pacemaker Market, by Technology 2020-2027, (USD Million)

    Table 8 Europe: Pacemaker Market, by Type 2020-2027, (USD Million)

    Table 21 Europe: Pacemaker Market, by End User 2020-2027, (USD Million)

    Table 22 Western Europe: Pacemaker Market, by Implantability 2020-2027, (USD Million)

    Table 23 Western Europe: Pacemaker Market, by Technology 2020-2027, (USD Million)

    Table 8 Western Europe: Pacemaker Market, by Type 2020-2027, (USD Million)

    Table 24 Western Europe: Pacemaker Market, by End User 2020-2027, (USD Million)

    Table 25 Eastern Europe: Pacemaker Market, by Implantability 2020-2027, (USD Million)

    Table 26 Eastern Europe: Pacemaker Market, by Technology 2020-2027, (USD Million)

    Table 8 Eastern Europe: Pacemaker Market, by Type 2020-2027, (USD Million)

    Table 27 Eastern Europe: Pacemaker Market, by End User 2020-2027, (USD Million)

    Table 28 Asia-Pacific: Pacemaker Market, by Implantability 2020-2027, (USD Million)

    Table 29 Asia-Pacific: Pacemaker Market, by Technology 2020-2027, (USD Million)

    Table 8 Asia-Pacific: Pacemaker Market, by Type 2020-2027, (USD Million)

    Table 30 Asia-Pacific: Pacemaker Market, by End User 2020-2027, (USD Million)

    Table 31 Middle East & Africa: Pacemaker Market, by Implantability 2020-2027, (USD Million)

    Table 32 Middle East & Africa: Pacemaker Market, by Technology 2020-2027, (USD Million)

    Table 8 Middle East & Africa: Pacemaker Market, by Type 2020-2027, (USD Million)

    Table 33 Middle East & Africa: Pacemaker Market, by End User 2020-2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation of the Global Pacemaker Market

    Figure 3 Market Dynamics of the Global Pacemaker Market

    Figure 4 Global Pacemaker Market Share, by Implantability, 2020

    Figure 5 Global Pacemaker Market Share, by Technology, 2020

    Figure 6 Global Pacemaker Market Share, by Type, 2020

    Figure 7 Global Pacemaker Market Share, by End User, 2020

    Figure 8 Global Pacemaker Market Share, by Region, 2020

    Figure 9 North America: Pacemaker Market Share, by Country, 2020

    Figure 10 Europe: Pacemaker Market Share, by Country, 2020

    Figure 11 Asia-Pacific: Pacemaker Market Share, by Country, 2020

    Figure 12 Middle East & Africa: Pacemaker Market Share, by Country, 2020

    Figure 13 Global Pacemaker Market: Company Share Analysis, 2020 (%)

    Figure 14 Medtronic plc: Key Financials

    Figure 15 Medtronic plc: Segmental Revenue

    Figure 16 Medtronic plc: Regional Revenue

    Figure 17 Abbott Laboratories: Key Financials

    Figure 18 Abbott Laboratories: Segmental Revenue

    Figure 19 Abbott Laboratories: Regional Revenue

    Figure 20 Boston Scientific: Key Financials

    Figure 21 Boston Scientific.: Segmental Revenue

    Figure 22 Boston Scientific: Regional Revenue

    Figure 23 Biotronik: Key Financials

    Figure 24 Biotronik: Segmental Revenue

    Figure 25 Biotronik: Regional Revenue

    Figure 26 Livanova: Key Financials

    Figure 27 Livanova: Segmental Revenue

    Figure 28 Livanova: Regional Revenue

    Figure 29 Lepu Medical: Key Financials

    Figure 30 Lepu Medical: Segmental Revenue

    Figure 31 Lepu Medical: Regional Revenue

    Figure 32 Osypka Medical: Key Financials

    Figure 33 Osypka Medical: Segmental Revenue

    Figure 34 Osypka Medical: Regional Revenue

    Figure 35 Oscor: Key Financials

    Figure 36 Oscor: Segmental Revenue

    Figure 37 Oscor: Regional Revenue

    Figure 38 Medico Spa: Key Financials

    Figure 39 Medico Spa: Segmental Revenue

    Figure 40 Medico Spa: Regional Revenue

    Figure 41 Shree Pacetronix: Key Financials

    Figure 42 Shree Pacetronix: Segmental Revenue

    Figure 43 Shree Pacetronix: Regional Revenue